CRISPR/Cas9 screen reveals that targeting TRIM34 enhances ferroptosis sensitivity and augments immunotherapy efficacy in hepatocellular carcinomaFeifan Yao, Suiqing Zhou,Ruizhi Zhang, Yining Chen,Wei Huang, Kai Yu, Nanmu Yang,Xiangjun Qian, Xiaofeng Tie,Jiali Xu,Yu Zhang,Tasiken Baheti,Jing Xu,Xinzheng Dai,Xiaopei Hao,Liren Zhang,Xuehao Wang,Qing LiCancer Letters（2024）引用 0|浏览7暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
